| 1 |
Dargenio VN, Dargenio C, Castellaneta S, De Giacomo A, Laguardia M, Schettini F, Francavilla R, Cristofori F. Intestinal Barrier Dysfunction and Microbiota–Gut–Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder. Nutrients 2023;15:1620. [DOI: 10.3390/nu15071620] [Reference Citation Analysis]
|
| 2 |
Cao C, Li Q, Chen Y, Zou M, Sun C, Li X, Wu L. Untargeted Metabolomic Analysis Reveals the Metabolic Disturbances and Exacerbation of Oxidative Stress in the Cerebral Cortex of a BTBR Mouse Model of Autism. J Mol Neurosci 2023;73:15-27. [PMID: 36574152 DOI: 10.1007/s12031-022-02096-6] [Reference Citation Analysis]
|
| 3 |
Boktor JC, Adame MD, Rose DR, Schumann CM, Murray KD, Bauman MD, Careaga M, Mazmanian SK, Ashwood P, Needham BD. Global metabolic profiles in a non-human primate model of maternal immune activation: implications for neurodevelopmental disorders. Mol Psychiatry 2022;27:4959-73. [PMID: 36028571 DOI: 10.1038/s41380-022-01752-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Yang G, Weng Y, Zhao Y, Wang D, Luo T, Jin Y. Transcriptomic and targeted metabolomic analysis revealed the toxic effects of prochloraz on larval zebrafish. Science of The Total Environment 2022;822:153625. [DOI: 10.1016/j.scitotenv.2022.153625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Aslan O, Kardaş B, Özbek MN, Ercan B. Evaluation of carnitine levels in dried blood spot samples in children with autism spectrum disorder. Turkish Journal of Biochemistry 2021;46:541-548. [DOI: 10.1515/tjb-2020-0420] [Reference Citation Analysis]
|
| 6 |
Peralta-Marzal LN, Prince N, Bajic D, Roussin L, Naudon L, Rabot S, Garssen J, Kraneveld AD, Perez-Pardo P. The Impact of Gut Microbiota-Derived Metabolites in Autism Spectrum Disorders. Int J Mol Sci 2021;22:10052. [PMID: 34576216 DOI: 10.3390/ijms221810052] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Likhitweerawong N, Thonusin C, Boonchooduang N, Louthrenoo O, Nookaew I, Chattipakorn N, Chattipakorn SC. Profiles of urine and blood metabolomics in autism spectrum disorders. Metab Brain Dis 2021. [PMID: 34338974 DOI: 10.1007/s11011-021-00788-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Bene J, Szabo A, Komlósi K, Melegh B. Mass Spectrometric Analysis of L-carnitine and its Esters: Potential Biomarkers of Disturbances in Carnitine Homeostasis. Curr Mol Med 2020;20:336-54. [PMID: 31729298 DOI: 10.2174/1566524019666191113120828] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Kępka A, Ochocińska A, Chojnowska S, Borzym-Kluczyk M, Skorupa E, Knaś M, Waszkiewicz N. Potential Role of L-Carnitine in Autism Spectrum Disorder. J Clin Med 2021;10:1202. [PMID: 33805796 DOI: 10.3390/jcm10061202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Needham BD, Adame MD, Serena G, Rose DR, Preston GM, Conrad MC, Campbell AS, Donabedian DH, Fasano A, Ashwood P, Mazmanian SK. Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry 2021;89:451-62. [PMID: 33342544 DOI: 10.1016/j.biopsych.2020.09.025] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 31.0] [Reference Citation Analysis]
|
| 11 |
El-Ansary A, Chirumbolo S, Bhat RS, Dadar M, Ibrahim EM, Bjørklund G. The Role of Lipidomics in Autism Spectrum Disorder. Mol Diagn Ther 2020;24:31-48. [PMID: 31691195 DOI: 10.1007/s40291-019-00430-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 12 |
Pacheva I, Ivanov I. Targeted Biomedical Treatment for Autism Spectrum Disorders. Curr Pharm Des 2019;25:4430-53. [PMID: 31801452 DOI: 10.2174/1381612825666191205091312] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Shen L, Liu X, Zhang H, Lin J, Feng C, Iqbal J. Biomarkers in autism spectrum disorders: Current progress. Clinica Chimica Acta 2020;502:41-54. [DOI: 10.1016/j.cca.2019.12.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 14 |
Guevara-Campos J, González-Guevara L, Guevara-González J, Cauli O. First Case Report of Primary Carnitine Deficiency Manifested as Intellectual Disability and Autism Spectrum Disorder. Brain Sci 2019;9:E137. [PMID: 31200524 DOI: 10.3390/brainsci9060137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Demarquoy C, Demarquoy J. Autism and carnitine: A possible link. World J Biol Chem 2019; 10(1): 7-16 [PMID: 30622681 DOI: 10.4331/wjbc.v10.i1.7] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Shen L, Zhao Y, Zhang H, Feng C, Gao Y, Zhao D, Xia S, Hong Q, Iqbal J, Liu XK, Yao F. Advances in Biomarker Studies in Autism Spectrum Disorders. Adv Exp Med Biol 2019;1118:207-33. [PMID: 30747425 DOI: 10.1007/978-3-030-05542-4_11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 17 |
[DOI: 10.1101/2020.05.17.098806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
